Results

Total Results: 2,080 records

Showing results for "drug".

361. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs. c. … Does this appear to be a different/off-label use of an available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device? … Food and Drug Administration [FDA] approved) and the specific clinical indication for which they are … Designation Database 12 A database of drugs that have received orphan drug status.

362. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs. c. … Does this appear to be a different/off-label use of an available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device? … Food and Drug Administration [FDA] approved) and the specific clinical indication for which they are … Designation Database 12 A database of drugs that have received orphan drug status.

363. Assessing Applicability: Interactive Case Study Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
     September 02, 2013 - The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may … The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may … The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may … The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may

364. Assessing Applicability: Interactive Case Study Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
     September 02, 2013 - The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may … The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may … The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may … The impact of a drug on bone mineral density in young, male, well-trained astronauts in outer space may

365. Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis – An Update of the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
     May 14, 2010 - Food and Drug Administration (FDA) issued a warning in January 2008 linking the use of bisphosphonates … For titles obtained from the search for AEs by drug of interest, titles will be accepted if they suggest … that the manuscript includes information on the relationship between the AE and the drug. … Drug Labeling Change to Pamidronate (Aredia) Regarding Link to Renal Failure.

366. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - Objectives for the Systematic Review Atypical antipsychotics are approved by the United States Food and Drug … To arrive at a quantitative measure, we will use the Jadad scale, which was developed for drug trials2 … The evidence of risks (adverse events) will be summarized within drug (each atypical antipsychotic separately … severely symptomatic persons have higher scores, a negative effect size indicates that the atypical drug

367. Cer-238-Cervical-Ripening-Appendix-E-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
     January 01, 2009 - Inpatient: After administration of the study drug a further minimum of 20 minutes or more of electronic … Outpatient: After administration of the study drug patients underwent 40 minutes of electronic fetal … After administration of study drug, all patients underwent continuous FHR monitoring for 3 hours. … There is no mention of fetal monitoring following the administration of the study drug. … Placebo (Provider NR) -See protocol for intervention 1 NA NA All patients Four hours after the drug

368. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-women
     March 10, 2009 - Appropriateness for EHC Program Does your question include a health care drug, intervention, device

369. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
     September 30, 2015 - the trial did not indicate clear differences between treatments for pain, functioning, depression, or drug … Excluded patients with history of psychosis Substance use: Excluded patients with history of illicit drug … stroke, and intracranial hemorrhage), major depression, cancer, and those without previous related drug … applicable; NR = not reported; NRS = numeric rating scale; NSAID = non-steroidal anti-inflammatory drug … ; OAT = opioid agonist therapy; OR = odds ratio; OUD = opioid use disorder; PDMP = prescription drug

370. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
     January 01, 2017 - Both groups (treatment and usual care) received usual care, including drug treatment throughout the … Randomized controlled trials were evaluated with criteria developed by the Drug Effectiveness Review … Overall, no drug intervention had high-strength evidence for any outcome of interest, but we found … Among illicit drug users, differences between older SGAs were not found in rate or time to drug discontinuation … Methods for the drug effectiveness review project.

371. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - Is this a new molecular entity (drug), biologic, or device being developed for potential diffusion into … Is it subject to approval under FDA’s Investigational New Drug, Biologics Licensing, combination- product … Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs. … Does this appear to be a different/off-label use of an available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device?

372. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Is this a new molecular entity (drug), biologic, or generic formulation of a drug being developed for … Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs. … Does this appear to be a different/off-label use of a currently available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device? … Potential Device/Drug Cost Per Patient (if applicable) 12.

373. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
     January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Food and Drug administration (FDA) for the agent in late 2012. … have been used for ensuring intranasal delivery, including needle-less nostril syringes, a nasal drug … methods have been used, including needle-less syringes inserted into alternating nostrils, a nasal drug … Food and Drug Administration (FDA); 2010 Dec 20. 86 p.

374. Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
     November 01, 2011 - Food and Drug Administration. Drug Safety and Risk Management Advisory Committee Meeting. … Food and Drug Administration. … Drug Safety and Risk Management Advisory Committee Meeting. 2006. 34. … Pharmacoepidemiol Drug Saf 2009;18(11):1064-1071. 36. … Thus, covariates were measured at drug initiation. Table K-1a.

375. Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/protocol
     January 11, 2019 - Designing drug trials: considerations for pregnant women. … Food and Drug Administration. … Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):1013-8. doi: 10.1002/pds.3495. PMID: 23893932. … Allergies" OR "Drug Dependency" OR "drug effects" OR "Drug Sensitivity" OR harm* OR harms OR "Long Term … Therapy"[Mesh] OR "drug therapy"[Subheading] OR drug*[tiab] OR pharmacotherap*[tiab] OR pharmacologic

376. Developing Methods to Assess Health Outcomes in the Presence of Competing Risks for Effectiveness Research | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/health-outcomes-competing-risks/abstract
     February 11, 2010 - Pharmacoepidemiol Drug Saf 2012 May;21(Suppl 2):121-9. PMID: 22552987. … Methods Demonstration was with a trial of drug therapy to prevent mortality and an accompanying registry

377. Acute Treatments for Episodic Migraine | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/migraine-treatments/protocol
     January 08, 2020 - other characteristics (e.g. older population, pregnant/breastfeeding women, patients with history of drug … screening; (5) use of prescription drug monitoring program data; (6) availability of close follow-up … screening Use of prescription drug monitoring program data Availability of close follow-up And … Drug Healthc Patient Saf. 2018;10:37-43. doi: 10.2147/DHPS.S151073. PMID: 29760569. … Canadian Headache Society Guideline: acute drug therapy for migraine headache.

378. Hepatitis-C-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
     November 01, 2012 - The strongest risk factor for HCV infection is injection drug use. … The prevalence of HCV infection in injection drug users varies widely depending on age, duration of … injection drug use, and other factors (such as availability and use of needle exchange programs).15 … Prevalences range from less than 50 percent in more recent studies of younger injection drug users … Drug Alcohol Depend. 2009;105(1-2):160-3. PMID: 19647375. 80.

379. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - Although any synthetic drug can be labeled "chemotherapy" in general, medical, and oncologic parlance … The statement that tamoxifen is the only drug evaluated in premenopausal women has been added to this … US, was minimally evaluated and the major study cited was stopped for an excess of strokes on the drug … Results I like the consistent presentation of results by drug (tam vs. ralox, tam vs. … We assumed that women take the drug for 5 years and NNT estimates were calculated for a 5-year period

380. Developing Validated Algorithms to Ascertain Medical Procedures Used During Pregnancy | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/pregnancy-procedures/abstract
     December 15, 2009 - Pharmacoepidemiol Drug Saf 2011 Nov;20(11):1168-76. PMID: 22020902.